Amgen Inc.
Amgen
AMGN · NASDAQ
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $36.8B
- Assets
- $90.6B
- SEC filing
- DEF 14A
- Filed
- April 7, 2026
Executive Compensation
Compensation reported for Amgen’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Robert A. Bradway
Chief Executive Officer And President
$24.7M
Reported total
- Salary
- $1,925,409
- Stock awards
- $12,599,589
- Incentives
- $3,907,000
- Option awards
- $5,399,996
- Other
- $861,126
James E. Bradner
Executive Vice President, Research And Development
$8.6M
Reported total
- Salary
- $1,238,580
- Stock awards
- $3,359,787
- Incentives
- $2,175,000
- Option awards
- $1,439,965
- Other
- $426,535
Peter H. Griffith
Executive Vice President And Chief Financial Officer
$8.6M
Reported total
- Salary
- $1,223,994
- Stock awards
- $3,709,745
- Incentives
- $1,652,000
- Option awards
- $1,589,962
- Other
- $435,186
Murdo Gordon
Executive Vice President, Global Commercial Operations
$8.5M
Reported total
- Salary
- $1,233,189
- Stock awards
- $3,709,745
- Incentives
- $1,668,000
- Option awards
- $1,589,962
- Other
- $322,575
David M. Reese
Executive Vice President And Chief Technology Officer
$8.3M
Reported total
- Salary
- $1,306,721
- Stock awards
- $3,359,787
- Incentives
- $1,768,000
- Option awards
- $1,439,965
- Other
- $415,835
Robert A. Bradway
Chief Executive Officer And President
$24.7M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 7, 2026.
- Salary
- $1.9M
- Stock Awards
- $12.6M
- Option Awards
- $5.4M
- Incentives
- $3.9M
- Other
- $861K
Historical Compensation
Robert A. Bradway total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,925,409 | $12,599,589 | $24,693,120 |
| 2024 | $1,869,242 | $12,599,930 | $24,428,495 |
| 2023 | $1,786,977 | $11,138,503 | $22,643,650 |
Named Executive Officers
Robert A. Bradway
Chief Executive Officer And President
Amgen · AMGN
$24.7M
FY 2025 · DEF 14A
Peter H. Griffith
Executive Vice President And Chief Financial Officer
Amgen · AMGN
$8.6M
FY 2025 · DEF 14A
Murdo Gordon
Executive Vice President, Global Commercial Operations
Amgen · AMGN
$8.5M
FY 2025 · DEF 14A
David M. Reese
Executive Vice President And Chief Technology Officer
Amgen · AMGN
$8.3M
FY 2025 · DEF 14A
James E. Bradner
Executive Vice President, Research And Development
Amgen · AMGN
$8.6M
FY 2025 · DEF 14A
Source information
- Company
- Amgen Inc.
- Ticker
- AMGN · NASDAQ
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 7, 2026
- SEC accession number
- 0001193125-26-145588
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →